Skip to content
About
Our Mission
Leadership
Board of Directors
Advisors
Pipeline
Clinical Trial
Patients & Families
News & Events
Contact
Loading...
NEWS & EVENTS
News & Events
monimono
2018-04-18T09:41:47+00:00
12
2018
Ayala Pharmaceuticals Signs Deal to Develop and Commercialize AL102 in Combination with BCMA Targeting Agents in Multiple Myeloma
December 20, 2018
12
2018
Ayala Pharmaceuticals Announces First Patient Enrolled in Phase 2 Study of Lead Product Candidate AL101 for Adenoid Cystic Carcinoma with Notch Activated Mutations
December 17, 2018
06
2018
Ayala Pharmaceuticals Presents Phase 1b Data at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting for AL101, a Pan-Notch Inhibitor, in Patients with Locally Advanced or Metastatic Solid Tumors
June 4, 2018
04
2018
Ayala Notches Up $17M in Financing to Push BMS Drug into Phase 2
April 10, 2018
12
2017
Ayala Pharmaceuticals Enters Exclusive Worldwide License Agreement with Bristol-Myers Squibb (BMS) to Develop Cancer Treatments
December 6, 2017